Related Funds
Fund Name | Location |
AppCampus | Espoo, Finland, Southern Finland |
Beverly Capital | - |
Bright Horizons Family Solutions | Massachusetts, United States, Watertown |
China Bridge Capital | Beijing, Beijing, China |
Dayi Yanyue Guanli Zixun Youxian Gongsi | Chengguan District, China, Lhasa |
FreeBit Co, Ltd | Chiyoda, Japan |
Hyperdrive SEO Agency | - |
IGneous | Chile, Region Metropolitana, Santiago |
Intervale Capital | Cambridge, Massachusetts, United States |
Jinhui Chuangye Touzi | - |
Lattice Ventures | New York, New York, United States |
Masnavi Capital | - |
New Generation Media | China, Haikou, Hainan |
Pari Capital Group | Bayern, Germany, Munich |
Paul Run Holding | China, Guangdong, Shenzhen |
Paulson & Co. | New York, New York, United States |
Rainmatter Capital | India, Karnataka, Karnataka |
Ricoh Leasing | Japan, Tokyo |
Sistema Investimenti | Catania, Italy, Sicilia |
Tokai University | Chiyoda, Japan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Karius | $100M | 02 May 2024 | Redwood City, California, United States | ||
ArsenalBio | $220M | 06 Sep 2022 | South San Francisco, California, United States | ||
Neumora Therapeutics | $400M | 07 Oct 2021 | Watertown, Massachusetts, United States | ||
Delphinus Medical Technologies | $39M | 10 Sep 2015 | Michigan, United States | ||
Verana Health | $7M | 09 Feb 2015 | San Francisco, California, United States |
– Newsela, a US-based instructional content platform for K-12 classrooms, announced today a $100m Series D investment.
– Franklin Templeton and TCV led the round, with participation by Owl Ventures, Tao Capital Partners, Chan Zuckerberg Initiative, Waycross Ventures and several others.
– Newsela takes authentic, real world content from trusted sources and makes it instruction ready for K-12 classrooms.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Karius | $100M | 02 May 2024 | Redwood City, California, United States | ||
ArsenalBio | $220M | 06 Sep 2022 | South San Francisco, California, United States | ||
Neumora Therapeutics | $400M | 07 Oct 2021 | Watertown, Massachusetts, United States | ||
Delphinus Medical Technologies | $39M | 10 Sep 2015 | Michigan, United States | ||
Verana Health | $7M | 09 Feb 2015 | San Francisco, California, United States |